Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amicus Therapeutics Inc (NASDAQ:FOLD)

15.78
Delayed Data
As of Sep 21
 +0.86 / +5.76%
Today’s Change
4.41
Today|||52-Week Range
16.06
+217.51%
Year-to-Date
Largest transactions by value over  
NameTypeDateShares
traded
Share
price
Transaction
value
Since
transaction
Perceptive Advisors Llc
Buy7/13/20171,500,000$12.25$18.4M+26.04%
Perceptive Advisors Llc
Buy12/22/2016189,500$4.51$854.6K+248.34%
Perceptive Advisors Llc
Buy12/30/201694,750$4.96$470.0K+217.51%
Perceptive Advisors Llc
Buy12/29/201694,750$4.85$459.5K+222.70%
Campbell Bradley L
Chief Operating Officer
Sale3/02/201749,050$8.00$392.4K+112.38%
Barth Jay A
Chief Medical Officer
Buy6/19/201730,000$10.00$300.0K+59.72%
Barth Jay A
Chief Medical Officer
Sale6/19/201730,000$10.00$300.0K+59.72%
Campbell Bradley L
Chief Operating Officer
Sale1/03/201750,950$5.13$261.4K+207.60%
Do Hung /callidus/
Chief Scientific Officer
Sale5/15/201729,914$8.00$239.3K+105.20%
Do Hung /callidus/
Chief Scientific Officer
Sale5/19/201729,914$8.00$239.3K+103.09%
Page of 5